Hookipa Pharma (HOOK) Earnings Date, Estimates & Call Transcripts $0.84 +0.06 (+7.71%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Hookipa Pharma Earnings Summary Upcoming Q3 Earnings DateMay. 8Before Market OpensEstimatedConsensus EPS (Aug. 8) -$1.44 Actual EPS (Aug. 8) -$1.52 Missed By -$0.08 Actual Revenue (Aug. 8) $1.29MHookipa Pharma announced Q2 2024 earnings on August 8, 2024, reporting an EPS of -$1.52, which missed analysts' consensus estimates of -$1.44 by $0.08. Quarterly revenue was reported to be $1.29 million, below analyst estimates of $5.68 million. With a trailing EPS of -$3.52, Hookipa Pharma's earnings are expected to decrease next year, from ($1.75) to ($2.60) per share. Q2 2024 Earnings ResourcesQ2 2024 Earnings Report Quarterly Report (10-Q) Press Release (8-K)HOOK Upcoming EarningsHookipa Pharma's Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled on Monday, May 12, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Hookipa Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hookipa Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataHOOK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.HOOK Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Hookipa Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.18-$0.18-$0.18Q2 20251-$0.19-$0.19-$0.19Q3 20251-$0.20-$0.20-$0.20Q4 20251-$0.20-$0.20-$0.20FY 20254($0.77)($0.77)($0.77) Hookipa Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)--------8/8/2024--$1.44-$1.52 -$0.08-$1.52$5.68M$1.29M5/9/2024Q1 2024-$1.20$1.20+$2.40$0.13$3.20M$36.60M3/22/2024Q4 2023-$2.00-$1.10+$0.90-$3.60M$7.41M11/9/2023Q3 2023-$2.30-$1.70+$0.60-$0.17$3.39M$6.87M8/10/2023Q2 2023-$2.10-$2.20 -$0.10-$0.22$3.54M$2.68M5/11/2023Q1 2023-$2.40-$2.70 -$0.30-$0.27$3.75M$3.18M Hookipa Pharma Earnings - Frequently Asked Questions When is Hookipa Pharma's earnings date? Hookipa Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on HOOK's earnings history. Did Hookipa Pharma beat their earnings estimates last quarter? In the previous quarter, Hookipa Pharma (NASDAQ:HOOK) missed the analysts' consensus estimate of ($1.44) by $0.08 with a reported earnings per share (EPS) of ($1.52). Learn more on analysts' earnings estimate vs. HOOK's actual earnings. How much revenue does Hookipa Pharma generate each year? Hookipa Pharma (NASDAQ:HOOK) has a recorded annual revenue of $43.95 million. How much profit does Hookipa Pharma generate each year? Hookipa Pharma (NASDAQ:HOOK) has a recorded net income of -$81.58 million. HOOK has generated -$3.52 earnings per share over the last four quarters. What is Hookipa Pharma's EPS forecast for next year? Hookipa Pharma's earnings are expected to decrease from ($1.75) per share to ($2.60) per share in the next year. More Earnings Resources from MarketBeat Related Companies SCYX Earnings Date ITRM Earnings Date RVPH Earnings Date RMTI Earnings Date RNXT Earnings Date IRD Earnings Date LTRN Earnings Date OSTX Earnings Date NRXP Earnings Date CVKD Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Seismic Shift at Intel: Massive Layoffs Precede Crucial EarningsRocket Lab Lands New Contract, Builds Momentum Ahead of EarningsAmazon's Earnings Could Fuel a Rapid Breakout Tesla Earnings Miss, But Musk Refocuses and Bulls ReactQualcomm’s Range Narrows Ahead of Earnings as Bulls Step InWhy It May Be Time to Buy CrowdStrike Stock Heading Into EarningsCan IBM’s Q1 Earnings Spark a Breakout for the Stock? This page (NASDAQ:HOOK) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hookipa Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hookipa Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.